Anti-ILT4 antibodies and antigen-binding fragments Grant US-11897957-B2 United States of America 13 Feb 2024
Anti-ILT4 antibodies and antigen-binding fragments Grant US-11897956-B2 United States of America 13 Feb 2024
SIRPalpha-41BBL fusion protein and methods of use thereof Grant US-11897937-B2 United States of America 13 Feb 2024
ANTIBODIES AGAINST HLA-G, COMPOSITIONS CONTAINING ANTIBODIES AGAINST HLA-G, AND METHODS… N/A RU-2810326-C2 Russian Federation 26 Dec 2023
PD1-41BBL fusion protein and methods of use thereof Grant US-11702458-B2 United States of America 18 Jul 2023
PD1-CD70 fusion protein and methods of use thereof Grant US-11566060-B2 United States of America 31 Jan 2023
ANTIBODIES AGAINST ILT2 AND USE THEREOF Application WO-2022034524-A3 World Intellectual Property Organisation (WIPO) 28 Apr 2022
Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using… Grant US-11208487-B2 United States of America 28 Dec 2021
Anti-ILT4 antibodies and antigen-binding fragments Grant US-11053315-B2 United States of America 06 Jul 2021
ANTIBODIES AGAINST ILT2 AND USE THEREOF Application WO-2021028921-A1 World Intellectual Property Organisation (WIPO) 18 Feb 2021
Activation and expansion of NKG2C+ NK cells Grant US-10864245-B2 United States of America 15 Dec 2020
LEUCOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR 2 NEUTRALIZING ANTIBODIES Application WO-2020136145-A3 World Intellectual Property Organisation (WIPO) 13 Aug 2020
ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING… Application WO-2020069133-A1 World Intellectual Property Organisation (WIPO) 02 Apr 2020
ANTI-HLA-G ANTIBODIES AND USE THEREOF Application WO-2018091580-A1 World Intellectual Property Organisation (WIPO) 24 May 2018